It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

This strategic acquisition, which entails acquiring the perpetual licence of Velvette, aligns with Reliance's ongoing ...

Under the terms of this agreement, Beihai Biotech will be responsible for the manufacturing and supply of the product. Zydus ...

China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

China's agriculture ministry issued guidelines on Friday to promote biotech cultivation from 2024 to 2028, a ministry ...

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

House' star Lindsay Hubbard shares one child with boyfriend Turner Kufe. Here’s everything we know about Lindsay Hubbard's ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...